Rebecca A. Gallego is an author at Pfizer (United States) specializing in molecular docking, oncology, and molecular recognition.
Top concepts
MedicineOncologyPathologyImmunologyEngineeringDrug DiscoveryCancer ResearchSystems BiologyMolecular BiologyMolecular Docking
Publications per year
2018–2024
5
5
Ted W. Johnson, Rebecca A. Gallego, Alexei Brooun et al. · ACS Medicinal Chemistry Letters · 2018 · 21 citations · Full text
Drug Target, Engineering, Immunology +19
Rows per page
1–5 of 5